Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy
- PMID: 28285612
- DOI: 10.1016/S2095-4964(17)60313-3
Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and severe adverse effects related to cancer treatment. Unfortunately, although several agents and protocols have been proposed, no prophylactic strategies have yet to be proven useful. Therefore, new alternative therapies have been considered for CIPN prevention. Herbal medicine in Japan, called Kampo medicine, is derived from traditional Chinese medicine. Goshajinkigan (GJG) is a Kampo medicine, that is comprised of ten herbs. The aim of this work is to analyse the results of pre-clinical and clinical studies on the potential applications of GJG in CIPN prevention.
Similar articles
-
Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Support Care Cancer. 2018 Apr;26(4):1051-1059. doi: 10.1007/s00520-017-4028-6. Epub 2017 Dec 26. Support Care Cancer. 2018. PMID: 29280005
-
Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Int J Clin Oncol. 2018 Jun;23(3):434-442. doi: 10.1007/s10147-017-1229-4. Epub 2017 Dec 21. Int J Clin Oncol. 2018. PMID: 29270698
-
The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen.Int J Clin Oncol. 2011 Aug;16(4):322-7. doi: 10.1007/s10147-010-0183-1. Epub 2011 Jan 22. Int J Clin Oncol. 2011. PMID: 21258836 Clinical Trial.
-
Co-treatment with Gabapentinoid and Japanese Herbal Medicine Goshajinkigan for CIPN is Associated with Longer Duration and Higher Dose of Chemotherapy.Adv Ther. 2025 Jun;42(6):2833-2852. doi: 10.1007/s12325-025-03173-z. Epub 2025 Apr 19. Adv Ther. 2025. PMID: 40252163 Free PMC article.
-
Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.Eur J Cancer. 2012 Jun;48(9):1407-13. doi: 10.1016/j.ejca.2011.08.009. Epub 2011 Sep 8. Eur J Cancer. 2012. PMID: 21907570
Cited by
-
Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Support Care Cancer. 2018 Apr;26(4):1051-1059. doi: 10.1007/s00520-017-4028-6. Epub 2017 Dec 26. Support Care Cancer. 2018. PMID: 29280005
-
Mechanical allodynia triggered by cold exposure in mice with the Scn11a p.R222S mutation: a novel model of drug therapy for neuropathic pain related to NaV1.9.Naunyn Schmiedebergs Arch Pharmacol. 2021 Feb;394(2):299-306. doi: 10.1007/s00210-020-01978-z. Epub 2020 Sep 24. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 32970203 Free PMC article.
-
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?Nutrients. 2022 Jan 31;14(3):625. doi: 10.3390/nu14030625. Nutrients. 2022. PMID: 35276984 Free PMC article. Review.
-
Kampo Formulae for the Treatment of Neuropathic Pain ∼ Especially the Mechanism of Action of Yokukansan ∼.Front Mol Neurosci. 2021 Dec 14;14:705023. doi: 10.3389/fnmol.2021.705023. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34970116 Free PMC article. Review.
-
Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Int J Clin Oncol. 2018 Jun;23(3):434-442. doi: 10.1007/s10147-017-1229-4. Epub 2017 Dec 21. Int J Clin Oncol. 2018. PMID: 29270698
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical